Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Metabolic Syndrome (MetS) represents a constellation of markers that indicates a predisposition to diabetes, cardiovascular disease and other pathologic states. The definition and treatment are a matter of current debate and there is not general agreement on a precise definition or, to some extent, whether the designation provides more information than the individual components. We consider here five indicators that are central to most definitions and we provide evidence from the literature that these are precisely the symptoms that respond to reduction in dietary carbohydrate (CHO). Carbohydrate restriction is one of several strategies for reducing body mass but even in the absence of weight loss or in comparison with low fat alternatives, CHO restriction is effective at ameliorating high fasting glucose and insulin, high plasma triglycerides (TAG), low HDL and high blood pressure. In addition, low fat, high CHO diets have long been known to raise TAG, lower HDL and, in the absence of weight loss, may worsen glycemic control. Thus, whereas there are numerous strategies for weight loss, a patient with high BMI and high TAG is likely to benefit most from a regimen that reduces CHO intake. Reviewing the literature, benefits of CHO restriction are seen in normal or overweight individuals, in normal patients who meet the criteria for MetS or in patients with frank diabetes. Moreover, in low fat studies that ameliorate LDL and total cholesterol, controls may do better on the symptoms of MetS. On this basis, we feel that MetS is a meaningful, useful phenomenon and may, in fact, be operationally defined as the set of markers that responds to CHO restriction. Insofar as this is an accurate characterization it is likely the result of the effect of dietary CHO on insulin metabolism. Glucose is the major insulin secretagogue and insulin resistance has been tied to the hyperinsulinemic state or the effect of such a state on lipid metabolism. The conclusion is probably not surprising but has not been explicitly stated before. The known effects of CHO-induced hypertriglyceridemia, the HDL-lowering effect of low fat, high CHO interventions and the obvious improvement in glucose and insulin from CHO restriction should have made this evident. In addition, recent studies suggest that a subset of MetS, the ratio of TAG/HDL, is a good marker for insulin resistance and risk of CVD, and this indicator is reliably reduced by CHO restriction and exacerbated by high CHO intake. Inability to make this connection in the past has probably been due to the fact that individual responses have been studied in isolation as well as to the emphasis of traditional therapeutic approaches on low fat rather than low CHO. We emphasize that MetS is not a disease but a collection of markers. Individual physicians must decide whether high LDL, or other risk factors are more important than the features of MetS in any individual case but if MetS is to be considered it should be recognized that reducing CHO will bring improvement. Response of symptoms to CHO restriction might thus provide a new experimental criterion for MetS in the face of on-going controversy about a useful definition. As a guide to future research, the idea that control of insulin metabolism by CHO intake is, to a first approximation, the underlying mechanism in MetS is a testable hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“[62] showed the effect of substitution of different fat sources or carbohydrate for the fat in the average US diet at 10% of energy.”
BackgroundA Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794 · cited 7×
“In addition to studies in which weight maintenance was a feature of experimental design it is important to consider data reported by Foster [45] (Figure 1, (Table 4), who compared low CHO and LF diets.”
BackgroundInfluentialDansinger, M. L., Gleason, J. A., Griffith, J. L., Selker, H. P., & Schaefer, E. J. (2005) · JAMA · doi:10.1001/jama.293.1.43 · Cited by 1,726 · cited 1×
“Experiment in reference [106] was carried out for a longer time period but diets became very similar.”
ResultGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267 · cited 1×
“It is notable that Samaha et al studied a population in which 39 % had diabetes and 43% had MetS [46].”
MethodLamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Yancy, W. S., Olsen, M. K., Guyton, J. R., Bakst, R. P., & Westman, E. C. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00006 · Cited by 946
Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934
Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review
Hu, F. B., Manson, J. E., & Willett, W. C. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719008 · Cited by 902
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Stern, L., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, M., Gracely, E. J., & Samaha, F. F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00007 · Cited by 831
Brehm, B. J., Seeley, R. J., Daniels, S. R., & D’Alessio, D. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021480 · Cited by 830
Hunt, K. J., Resendez, R. G., Williams, K., Haffner, S. M., & Stern, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000140762.04598.f9 · Cited by 662 · cited 1×
“Reaven's 1988 Banting lecture is generally considered a turning point in codifying a unifying principle under the name of MetS or Syndrome X (Reviews: [ 1-7 ].”
BackgroundBoden, G., Sargrad, K., Homko, C., Mozzoli, M., & Stein, T. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00006 · Cited by 542
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531 · cited 4×
“Berglund L, Oliver EH, Fontanez N, Holleran S, Matthews K, Roheim PS, Ginsberg HN, Ramakrishnan R, Lefevre M: HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects.”
BackgroundInfluentialParks, E. J., & Hellerstein, M. K. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.412 · Cited by 530
Gannon, M. C., & Nuttall, F. Q. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2375 · Cited by 428 · cited 1×
“Most recently, this group has shown the benefit of a 20 % CHO diet with higher protein [57].”
BackgroundAn increase in dietary protein improves the blood glucose response in persons with type 2 diabetes
Gannon, M. C., Nuttall, F. Q., Saeed, A., Jordan, K., & Hoover, H. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.734 · Cited by 404
A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men
Sharman, M. J., Kraemer, W. J., Love, D. M., Avery, N. G., Gómez, A. L., Scheett, T. P., & Volek, J. S. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.7.1879 · Cited by 312
Self-citationA ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
Van der Auwera, I., Wera, S., Van Leuven, F., & Henderson, S. T. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-28 · Cited by 307
McAuley, K. A., Hopkins, C. M., Smith, K. J., McLay, R. T., Williams, S. M., Taylor, R. W., & Mann, J. I. (2005) · Diabetologia · doi:10.1007/s00125-004-1603-4 · Cited by 275
Meckling, K. A., O’Sullivan, C., & Saari, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031606 · Cited by 233
Volek, J., Sharman, M., Gómez, A., Judelson, D., Rubin, M., Watson, G., Sokmen, B., Silvestre, R., French, D., & Kraemer, W. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-13 · Cited by 175
Self-citationSeshadri, P., Iqbal, N., Stern, L., Williams, M., Chicano, K. L., Daily, D. A., McGrory, J., Gracely, E. J., Rader, D. J., & Samaha, F. F. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.009 · Cited by 169
Modification of Lipoproteins by Very Low-Carbohydrate Diets
Volek, J. S., Sharman, M. J., & Forsythe, C. E. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1339 · Cited by 159
Self-citationCoronary heart disease in seven countries
Keys, A. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00410-8 · Cited by 154
Cornier, M., Donahoo, W. T., Pereira, R., Gurevich, I., Westergren, R., Enerback, S., Eckel, P. J., Goalstone, M. L., Hill, J. O., Eckel, R. H., et al. (2005) · Obesity Research · doi:10.1038/oby.2005.79 · Cited by 140 · cited 4×
“We have shown this argument is based on misunderstanding of the laws of thermodynamics [39,47-49] and the effect of variable efficiency is now better accepted [50,51].”
BackgroundInfluentialA review of low-carbohydrate ketogenic diets
Westman, E. C., Mavropoulos, J., Yancy, W. S., & Volek, J. S. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0038-6 · Cited by 133 · cited 1×
“Beyond spontaneous caloric reduction, however, it has been shown that the macronutrient composition of the diet can affect the efficiency of energy utilization and greater efficacy, the so-called metabolic advantage, of low CHO diets compared to LF diets has been the subject of several reports (Reviews: [39,41].”
BackgroundSelf-citationEffects of high-protein, low-carbohydrate dieting on plasma lipoproteins and body weight
LAROSA, J. C., FRY, A. G., MUESING, R., & ROSING, D. R. (1980) · Journal of the American Dietetic Association · doi:10.1016/s1094-7159(21)03514-5 · Cited by 116 · cited 3×
“In studies mentioned above, subjects did not significantly increase fat or protein intake but merely removed CHO from their diets [23-25].”
BackgroundDietary-Fat Intake in the US Population
Kennedy, E. T., Bowman, S. A., & Powell, R. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718853 · Cited by 116 · cited 1×
“Most important, the fact that, in the obesity and diabetes epidemic, fat consumption went down (for men, the absolute amount) and carbohydrate consumption went up [21,22], means that other approaches should be considered.”
BackgroundPostprandial glycemia, glycemic index, and the prevention of type 2 diabetes
Brand-Miller, J. C. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.243 · Cited by 107 · cited 1×
“Further, experimental results show an improvement in lipid outcomes (discussed below), no damage to normal kidneys [27], the potentially beneficial rather than deleterious effects of ketone bodies [28-30] and the prevalence of strategies based on low glycemic index [31,32] or reduction of refined CHO or sweets, all ap…”
Background"A calorie is a calorie" violates the second law of thermodynamics
Feinman, R. D., & Fine, E. J. (2004) · Nutrition Journal · doi:10.1186/1475-2891-3-9 · Cited by 104 · cited 1×
“We have shown this argument is based on misunderstanding of the laws of thermodynamics [39, 47-49 ] and the effect of variable efficiency is now better accepted [50,51].”
Self-citationThe case for low carbohydrate diets in diabetes management
Arora, S. K., & McFarlane, S. I. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-16 · Cited by 102 · cited 2×
“In reading recent reviews of low CHO diets [ 12 ,13], we were struck by the fact that the symptoms of MetS are precisely the ones targeted by diets that restrict CHO.”
BackgroundThermodynamics and Metabolic Advantage of Weight Loss Diets
Feinman, R. D., & Fine, E. J. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903322716688 · Cited by 98
Self-citationVery-low-carbohydrate weight-loss diets revisited.
Volek, J. S., & Westman, E. C. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.11.849 · Cited by 77
Self-citationHays, J. H., DiSabatino, A., Gorman, R. T., Vincent, S., & Stillabower, M. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.11.1331 · Cited by 50 · cited 1×
“In general, a growing body of work has shown improvement in LDL pattern switching from high CHO to low CHO diets [42,43,72-75].”
BackgroundEffect of High-Carbohydrate Feeding on Triglyceride and Saturated Fatty Acid Synthesis
Hudgins, L. C. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22521.x · Cited by 49
Cited by
Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., et al. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.011 · Cited by 912
“Carbohydrate restriction is the single most effective intervention for reducing all of the features of metabolic syndrome [5,62, 69].”
Self-citationWestman, E. C., Yancy, W. S., Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-36 · Cited by 475
Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet
Volek, J. S., Phinney, S. D., Forsythe, C. E., Quann, E. E., Wood, R. J., Puglisi, M. J., Kraemer, W. J., Bibus, D. M., Fernandez, M. L., & Feinman, R. D. (2009) · Lipids · doi:10.1007/s11745-008-3274-2 · Cited by 397
“In summary, our results are consistent with previous work showing the benefit of CRD compared to LFD [13, 34, 41].”
BackgroundResultSelf-citationLow-carbohydrate nutrition and metabolism
Westman, E. C., Feinman, R. D., Mavropoulos, J. C., Vernon, M. C., Volek, J. S., Wortman, J. A., Yancy, W. S., & Phinney, S. D. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.276 · Cited by 379
Self-citationForsythe, C. E., Phinney, S. D., Fernandez, M. L., Quann, E. E., Wood, R. J., Bibus, D. M., Kraemer, W. J., Feinman, R. D., & Volek, J. S. (2008) · Lipids · doi:10.1007/s11745-007-3132-7 · Cited by 371
Self-citation
Metadata
- Authors
- Volek, J. S., & Feinman, R. D.
- Venue
- Nutrition & Metabolism
- Published
- 2005-11-16
- Volume
- 2
- Issue
- 1
- Pages
- 31-31
- ISSN
- 1743-7075 (ISSN-L)
- OpenAlex
- W2155564116
- Cited by
- 226
- References
- 39
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.